Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC

Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. Sorafenib (Sora) is used as a targeted therapy for HCC treatment. Mesenchymal stem cells (MSCs) are applied as a new approach to fight malignancies. Drug res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Hajighasemlou, Saieh, Nikbakht, Mohsen, Pakzad, Saeedreza, Muhammadnejad, Samad, Gharibzadeh, Safoora, Mirmoghtadaei, Milad, Zafari, Fariba, Seyhoun, Iman, Ai, Jafar, Verdi, Javad
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312705/
https://ncbi.nlm.nih.gov/pubmed/32617114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9602728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados